Treatment of Memory Impairment, Vertigo and Tinnitus in the Elderly with Piribedil in an Indian General Practice Setting

Journal of the Indian Medical Association

Volumn 101, Issue 8, 2003, Pages 500-501

  Hastak, S M ^a  

^a LILAVATI HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

Dopamine; Neurotransmitters; Quality of life

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; PIRIBEDIL;

ADULT; AGED; ARTICLE; DROWSINESS; DRUG EFFICACY; FEMALE; GASTRITIS; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEMORY DISORDER; PATIENT COMPLIANCE; QUALITY OF LIFE; SIDE EFFECT; TINNITUS; VERTIGO;

EID: 0347418095     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ollat H - Dopaminergic insufficiency reflecting cerebral ageing: value of a dopaminergic agonist, piribedil. J Neurol 1992; 239: S13-6.
2. Volkow ND, Gur RC, Wang GJ, Fowler JS, Moberg PJ, Ding YS, et al. - Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry 1998; 155: 344-9.
3. Derouesne C - Mnesic complaints in elderly. Rev Pract 1994; 44: 1432-5.
4. Altschuler RA, Hoffman DW, Wenthold RJ - Neurotransmitters of the cochlea and cochlear nucleus: immunocytochemical deficiency. Am J Otolaryngol 1986; 7: 100-6.
5. Sataloff J, Sataloff RT, Lueneburg W. Tinnitus and vertigo in healthy senior citizens without a history of noise exposure. Am J Otology 1987; 8: 87-9.
6. McClure JA - Vertigo and imbalance in the elderly. J Otolaryngol 1986; 15: 248-52.
7. Scholing WE, Clausen HD - Trivastal and cerebral circulatory, insufficiency in the elderly subject. Extraits des Cahiers Medicaux 1975; 1: 525-7.
8. Nagraja D, Jayashree S - Randomised study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment. Am J Psychiatry 2001; 158: 1517-9.
9. Lassere P, Coppolani T - National multicenter trial in 6000 patients (hospitalized patients and out patients) of Trivastal retard 50, 1 tablet per day, in treatment of cerebral insufficiency. La Vie Médicale 1980; 61: 39-50.
10. Lambrozo J - Value of Trivastal LA in the long-term treatment of chronic cerebral insufficiency. National multicenter study involving 2758 patients. Comptes Rendus de Thérapeutiques 1983; 1: 9-19.
11. Pocock SJ, Elbourne DA - Randomised trials or observational tribulations? N Engl J Med 2000; 342: 1907-9.